Third Arc Bio is paying $5 million upfront to use Adagene’s tech in hopes of creating two new masked T-cell engagers. | Third ...

Circle's dual offerings seek to modernize institutional cross-border currency trading with real-time settlement.

The USDC issuer's new stablecoin foreign exchange engine aims to modernize cross-border payments, reduce risk and streamline ...

Shares debuts two crypto index ETFs regulated under the SEC’s 1940 Act, offering diversified exposure with traditional fund ...